Over the past few decades, engineers have developed various devices that can create holograms, three-dimensional (3D) or ...
Quantum materials, materials exhibiting physical behavior governed by the laws of quantum mechanics, have proved promising ...
Morning Overview on MSN
Capivasertib won FDA approval for a hard-to-treat form of prostate cancer
Men diagnosed with metastatic prostate cancer that lacks the PTEN protein now have a targeted drug option for the first time.
Evommune, Inc. (NYSE: EVMN) (the "Company" or "Evommune"), a clinical-stage biotechnology company developing innovative ...
Findings provide mechanistic support for previously reported clinical outcomes of clinical reversal of platinum resistance/refractoriness from ...
Parties discussed information provided by Newron and changes needed by FDA to consider re-start of enrollment in ENIGMA-TRS 2 ...
Sionna Therapeutics targets cystic fibrosis with novel CFTR/NBD1 stabilization; key 2026 readouts and cash runway to 2028.
Bupropion conferred modest reductions in cancer-related fatigue compared with placebo, according to results of a randomized ...
Newron Pharmaceuticals provides update following Type A meeting with the US FDA: Milan, Italy Saturday, July 4, 2026, 10:00 Hrs [IST] Newron Pharmaceuticals S.p.A. (Newron), a bio ...
Artelo Biosciences, Inc. (Nasdaq: ARTL), a clinical-stage pharmaceutical company focused on modulating lipid-signalling pathways to develop treatments for people living with cancer, pain, dermatologic ...
The wAIHA market landscape is undergoing a significant evolution after years of dependence on broad immunosuppressive ...
An analytical guide to cellular optimization, epigenetic switches, and the daily disciplines that preserve youth from the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results